RxDoctor Payments DataLook up a doctor →

Adam Meszaros, MD

Rheumatology · Columbia, SCNPI 1780105049

Payments from drug & device makers

$6,727in general payments, 2019–2025

Across 304 payments — averaging $22.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • UCB, Inc.$1K
  • Johnson & Johnson$1K
  • AbbVie$974
  • Novartis$683
  • E.r. Squibb & Sons, L.L.C.$462
  • plus $861 from 12 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,727 in reported general payments places this provider in the 55th percentile of 123 rheumatology providers in South Carolina.

See all rheumatology providers in South Carolina

Medicare billing

Part B allowed, 2024
$2,612,600
Medicare patients
157
Services billed
112,543

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →